# A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes

> **NCT01999322** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 37 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Faster-acting insulin aspart
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT01999322
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-19
- **Primary completion:** 2014-05-14
- **Final completion:** 2014-05-14
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999322, "A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01999322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*